ASX:IMMPharmaceuticals, Biotechnology & Life SciencesBiotechnology
IMMUTEP ORD
$0.044
$0.002 (4.35%)
Day Range
$0.044 - $0.046
52 Week Range
$0.028 - $0.470
Volume
12.86M
Avg Volume (10D)
19.38M
Market Cap
$64.84M
Price Chart
Market Statistics
Open$0.046
Previous Close$0.046
Day High$0.046
Day Low$0.044
52 Week High$0.470
52 Week Low$0.028
Valuation
Market Cap64.84M
Shares Outstanding1.47B
Price to Book0.66
Trading Activity
Volume12.86M
Value Traded573.74K
Bid$0.044 × 749,995
Ask$0.045 × 140,570
Performance
1 Day-4.35%
5 Day-4.35%
13 Week-89.40%
52 Week-83.40%
YTD-89.40%
Technical Indicators
RSI (14)17.78
50-Day SMA$0.292
200-Day SMA$0.287
Latest News
Hot Topics
Weekly Wrap: Shares fall another 2.6% for the week as conflict worsens
ASX 200 slides 2.6% this week to 8,617 as Iran-Israel conflict lifts oil above $100; NST and SYR plunge, while EOS soars on a Middle East contract.
3 min read
Biotechnology
Immutep doses first patient in Phase II/III efti trial to treat metastatic breast cancer
Biotechnology company Immutep (ASX: IMM) has safely dosed the first patient at a European clinical site for its integrated Phase II/III AIPAC-003 trial to treat metastatic breast cancer. AIPAC-003 is evaluating the company’s soluble LAG-3 protein and first-in-class MHC Class II agonist known as eftilagimod alpha (efti) in combination with standard-of-care paclitaxel for the treatment […]
2 min read
